In this framework, it is clear that further investigations should be conducted in ALK+ ALCL to determine whether apoptosis or necroptosis could occur secondarily to autophagy in crizotinib-treated cells to ensure lymphoma cells’ full eradication, as observed following ALK and BCL2 or ALK and RAF1 combined inactivation. The gene discussed is RAF1; the disease is lymphoma.